76
47
Growth Score 76 in past quarter
-12 pts
Heat Score 47 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3891436
IBEX markets a line of recombinant high-purity proprietary enzymes from Flavobacterium heparinum.
About the Company
IBEX Technologies Inc is a Canada-based Company that manufactures and markets enzymes for biomedical use. The company produces a family of high purity recombinant glycosaminoglycan (GAG) lyases, namely Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC and Chondroitinase B. It also produces a series of arthritis assays which are used by
pharmaceutical companies for research purposes. The Company has proprietary expression system in Flavobacterium heparinum and produces these enzymes at the highest purity. Heparinase I rapidly and specifically neutralize both unfractionated heparin as well as low molecular weight heparin, allowing baseline hemostasis to be monitored in the presence of these anticoagulants.
